To amend the Internal Revenue Code of 1986 to impose an excise tax on sales of syringes and intravenous systems which do not meet antineedlestick prevention standards.

Summary

Amends the Internal Revenue Code to impose an excise tax from 1997 through 1999 on sales of syringes and intravenous systems which do not meet antineedlestick prevention standards. Imposes such tax on sales by the manufacturer, producer, or importer. Directs the Commissioner of the Food and Drug Administration to prescribe safety standards for syringes, and appropriate components of intravenous systems, to prevent accidental needlestick injuries.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

2 official files

• Introduced in House (text)

  Introduced in House · EN

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 27 February 1992

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.